Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleosome assembly protein 1 like 1 pseudogene 3 (NAP1L1P3) is a nonfunctional segment of DNA classified as a pseudogene, bearing sequence similarity to the functional NAP1L1 gene but lacking coding or regulatory capacity for a functional protein[4][7]. Pseudogenes like NAP1L1P3 are usually not transcribed or translated into active proteins and do not contribute directly to cell biology or disease except in rare cases where pseudogenes may have regulatory roles as noncoding RNAs, which is not documented for NAP1L1P3 specifically[4][2][7]. Its functional counterpart, NAP1L1, is involved in chromatin assembly, DNA replication, and cell proliferation, but these roles are not shared by the pseudogene variant[1][7]. In summary, NAP1L1P3 should not be considered a therapeutic target, and there is no evidence of biological or disease relevance, interacting drugs, mechanism of action, biomarkers, or safety concerns. All functional information relates instead to its parent gene, NAP1L1, not to NAP1L1P3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome assembly protein 1 like 1 pseudogene 3 (NAP1L1P3).